|
|
Volumn 345, Issue , 2012, Pages
|
|
Neurologists appeal to health secretary over withdrawal of drug for MS patients.
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ALEMTUZUMAB;
MONOCLONAL ANTIBODY;
DRUG INDUSTRY;
DRUG RECALL;
ETHICS;
HUMAN;
MULTIPLE SCLEROSIS;
NOTE;
OFF LABEL DRUG USE;
RANDOMIZED CONTROLLED TRIAL (TOPIC);
UNITED KINGDOM;
ANTIBODIES, MONOCLONAL, HUMANIZED;
DRUG INDUSTRY;
GREAT BRITAIN;
HUMANS;
MULTIPLE SCLEROSIS, RELAPSING-REMITTING;
OFF-LABEL USE;
RANDOMIZED CONTROLLED TRIALS AS TOPIC;
SAFETY-BASED DRUG WITHDRAWALS;
|
|
EID: 84872026332
PISSN: None
EISSN: 17561833
Source Type: Journal
DOI: 10.1136/bmj.e7449 Document Type: Note |
|
Times cited : (2)
|
|
References (0)
|
